Effect of Dupilumab on ASS Intolerance and Its Mechanisms in Patients With Aspirin-exacerbated Respiratory Disease (AERD)
Latest Information Update: 03 Apr 2024
At a glance
- Drugs Dupilumab (Primary)
- Indications Allergic asthma; Nasal polyps; Respiration disorders; Rhinosinusitis
- Focus Therapeutic Use
Most Recent Events
- 29 Jul 2020 Planned number of patients changed from 40 to 30.
- 29 Jul 2020 The treatments section is updated to reduce the number of arms from 2 to 1 by removing Aspirin Arm. The planned enrolment is therefore reduced from 40 to 30 patients.
- 26 Jun 2020 New trial record